user
menu
letter
Sign InRegister
langEnglisharrow

Claudin-18.2

Claudin-18.2

Claudin-18.2 Overview

Molecule Name
Claudin-18 splice variant 2
Synonyms
Claudin-18.2,CLDN18,Claudin-18
Drug Development Progress
Drugs in Clinical Trials85
Approved Drugs1
Highest Development StageApproved
Target Synonym
UNQ778/PRO1572，CLDN18，Claudin 18，Surfactant Associated Protein J，Surfactant， Pulmonary Associated Protein J，Surfactant Associated 5，Claudin-18，SFTA5，SFTPJ，Claudin 18.2，CLDN18.2
Background
Claudins (CLDNs) are a family of proteins that form tight junctions and maintain the polarity of epithelial and endothelial cells. CLDN18 is specifically expressed in the stomach and lung. Of the two CLDN18 isoform transcripts produced by alternative splicing, CLDN18.2 is a highly selective gastric lineage marker that determines the gastric phenotype in a neoplastic condition, whereas CLDN18.1 is lung specific. CLDN18.2 is a highly selective gastric lineage antigen expressed exclusively on short-lived differentiated gastric epithelial cells where it has only limited accessibility to antibody drugs.14,15 CLDN18.2 is maintained during the course of malignant transformation and thus frequently displayed on the surface of human gastric cancer cells.

Claudin-18.2 Product List

Species
  • Human / Cynomolgus（6）
  • Human（4）
  • Mouse（2）
Tag
  • -（5）
  • His Tag & Strep Tag（4）
  • His Tag & Flag Tag（2）
  • GFP Tag（1）
Host
  • InsectCells（6）
  • HEK293（5）
  • E. coli（1）
Conjugate
  • Unconjugated（7）
  • Biotin-labeled（3）
  • GFP Fusion（1）
  • PE Labeled（1）
Grade
  • RUO（12）
Low Endotoxin
  • No（12）
MoleculeCat. No.Product NameSpeciesHostStructurePurityActivitySize&Price
Claudin-18.2
HOTAIDD‑Ready
CL2-H52P7
Human Claudin-18.2 Full Length Protein (VLP)
Human
HEK293
HPLC
ELISASPRIdentity

$620.00

20ug
Claudin-18.2
HOTAIDD‑Ready
CL2-M5585
Mouse Claudin-18.2 Protein, His,Twin-Strep Tag (Detergent)
Mouse
InsectCells
SDS-PAGE
ELISASPR

$845.00

20ug
Claudin-18.2
HOTAIDD‑Ready
CL2-H5587
Human / Cynomolgus Claudin-18.2 Protein, His,Twin-Strep Tag (Detergent)
Human / Cynomolgus
InsectCells
ELISASPRBLI

$1235.00

20ug
Claudin-18.2
HOTAvitag
CL2-H85D3
Biotinylated Human / Cynomolgus Claudin-18.2 Protein, His,Avitag™&Flag Tag (Detergent)
Human / Cynomolgus
InsectCells
SDS-PAGE
ELISA

$1340.00

20ug
Claudin-18.2
AIDD‑Ready
CL2-H51D3
Human Claudin-18.2 Full Length Protein, Flag,His Tag (Detergent)
Human
E. coli
ELISASPR

$496.00

20ug
Claudin-18.2
AIDD‑Ready
CL2-H5586
Human / Cynomolgus Claudin-18.2 Protein, His,Twin-Strep Tag (Nanodisc)
Human / Cynomolgus
InsectCells
ELISASPRFlow

$1440.00

20ug
Claudin-18.2
AIDD‑Ready
CL2-H5589
Human / Cynomolgus Claudin-18.2 Protein, His,Twin-Strep Tag (Nanodisc-pro)
Human / Cynomolgus
InsectCells
ELISASPRBLIFlow

$750.00

20ug
Claudin-18.2
CL2-H82P3
Biotinylated Human Claudin-18.2 Full Length Protein (VLP)
Human
HEK293
HPLC
ELISASPRIdentity

$620.00

20ug
Claudin-18.2
Avitag
CL2-H85D4
Biotinylated Human / Cynomolgus Claudin-18.2 Protein, His,Avitag™&Flag Tag (Nanodisc)
Human / Cynomolgus
InsectCells
ELISAFlow

$1955.00

20ug
Claudin-18.2
AIDD‑Ready
CL2-HF218
Fluorescent Human Claudin-18.2 Full Length Protein (VLP)
Human
HEK293
HPLC
ELISASPRFlowIdentity

$620.00

20ug
You Have Viewed 1-10 Of 12 Results
  • 1
  • 2

Can’t find what you need?

Submit your requirements and our technical
team will help.

Product InquiryRequest Customization
Asset Licensing Opportunity

Antibody Project Trading Platform

Project NameProject StageMolecule TypeMolecule SourceDisease AreaIndication
CLDN18.2 CAR-T - 01PhaseICARNanobodySolid TumorAdvanced refractory gastrointestinal tumors
CLDN18.2 VHH - 01LeadMonoclonalNanobodySolid TumorGastric Cancer,Pancreatic cancer
Project Name
CLDN18.2 CAR-T - 01
Project Stage
PhaseI
Molecule Type
CAR
Molecule Source
Nanobody
Disease Area
Solid Tumor
Indication
Advanced refractory gastrointestinal tumors
Project Name
CLDN18.2 VHH - 01
Project Stage
Lead
Molecule Type
Monoclonal
Molecule Source
Nanobody
Disease Area
Solid Tumor
Indication
Gastric Cancer,Pancreatic cancer

Project Cooperation

Project NameDrug TypeTherapeutic AreaIndicationStageRights Area
Claudin18.2×CD8+ T bsAbBispecific antibodyOncology/CancerGastric cancer,Pancreatic cancer,OophoromaINDGlobal
CLDN 18.2 CAR-TCell therapyOncology/CancerGastric Cancer,Pancreatic CancerINDGlobal
Claudin18.2 mAbMonospecific antibodyOncology/CancerGastric cancerPhase IGlobal
Project Name
Claudin18.2×CD8+ T bsAb
Drug Type
Bispecific antibody
Therapeutic Area
Oncology/Cancer
Indication
Gastric cancer,Pancreatic cancer,Oophoroma
Stage
IND
Rights Area
Global
Project Name
CLDN 18.2 CAR-T
Drug Type
Cell therapy
Therapeutic Area
Oncology/Cancer
Indication
Gastric Cancer,Pancreatic Cancer
Stage
IND
Rights Area
Global
Project Name
Claudin18.2 mAb
Drug Type
Monospecific antibody
Therapeutic Area
Oncology/Cancer
Indication
Gastric cancer
Stage
Phase I
Rights Area
Global
Resources

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
OsemitamabMSB-018; TST-001Phase 3 ClinicalHJB (Hangzhou) Co Ltd, Suzhou Transcenta Therapeutics Co Ltd
Biliary Tract Neoplasms; Esophageal Neoplasms; Gallbladder Neoplasms; Gastroesophageal Junction Neoplasms; Lung Neoplasms; Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
Details
XNW-27011XNW-27011Phase 3 ClinicalEvopoint Biosciences Co Ltd
Adenocarcinoma; Biliary Tract Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Gastroesophageal Junction Neoplasms; Ovarian Neoplasms; Solid tumours; Stomach Neoplasms
Details
IMC-002 (Suzhou Immunofoco)IMC-002Phase 3 ClinicalSuzhou Immunofoco Biotechnology Co Ltd
Digestive System Neoplasms; Gastroesophageal Junction Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Stomach Neoplasms
Details
Arcotatug tavatecanIBI-343; IBI343Phase 3 ClinicalInnovent Biologics(Suzhou) Co Ltd
Adenocarcinoma; Carcinoma, Pancreatic Ductal; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
Details
LB-4330LB-4330; Bis-2Phase 3 ClinicalL&L Biopharma Co Ltd
Solid tumours; Uterine Cervical Neoplasms
Details
JS-107JS-107; JS107Phase 3 ClinicalShanghai Junshi Biosciences Co Ltd
Adenocarcinoma; Gastroesophageal Junction Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
Details
Tecotabart vedotinTPX-4589; BMS-986476; LM-302Phase 3 ClinicalLaNova Medicines Ltd
Adenocarcinoma; Digestive System Neoplasms; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Gastrointestinal Neoplasms; Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
Details
QLS-31905QLS-31905Phase 3 ClinicalQilu Pharmaceutical Co Ltd
Bile Duct Neoplasms; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
Details
SYSA-1801SYSA1801; CPO-102; EO-3021; SYSA-1801Phase 3 ClinicalCSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd
Digestive System Neoplasms; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Gastrointestinal Neoplasms; Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
Details
Garetatug RezetecanSHR-A-1904; SHR-A1904Phase 3 ClinicalShanghai Hengrui Pharmaceutical Co Ltd
Bile Duct Neoplasms; Biliary Tract Neoplasms; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Lymphangioma, Cystic; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
Details
FG-M-108FG-M-108; M108; M-108Phase 3 ClinicalFutureGen Biopharm (Beijing) Co Ltd
Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
Details
Sonesitatug VedotinCMG-901; CMG901; AZD-0901; AZD0901Phase 3 ClinicalKeymed Biosciences Co Ltd
Biliary Tract Neoplasms; Carcinoma, Pancreatic Ductal; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
Details
ASKB-589ASKB-589Phase 3 ClinicalAskGene Pharma Inc, Jiangsu Aosaikang Pharmaceutical Co Ltd
Adenocarcinoma; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
Details
KD-182KD-182Phase 2 ClinicalNanjing Kaidi Medical Technology Co Ltd
Carcinoma, Pancreatic Ductal; Stomach Neoplasms
Details
CLDN18.2-TAC T cells TherapyCLDN-18.2-TAC T cells; CLDN18.2-TAC T cellsPhase 2 ClinicalTriumvira Immunologics Inc
Solid tumours; Stomach Neoplasms
Details
HBM-7022HBM-7022; AZD-5863Phase 2 ClinicalHarbour Biomed
Carcinoma, Pancreatic Ductal; Esophageal adenocarcinoma; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Neoplasms; Pancreatic Neoplasms; Stomach Neoplasms
Details
EB-DNK102EB-DNK102Phase 2 ClinicalBeijing Biotech
Carcinoma, Pancreatic Ductal
Details
Claudin18.2 targeting CAR-T cell therapy (Essen Biotech)Phase 2 ClinicalEssen Biotech
Pancreatic Neoplasms
Details
AZD-4360AZD4360; AZD-4360Phase 2 ClinicalAstrazeneca Ab
Biliary Tract Neoplasms; Carcinoma, Pancreatic Ductal; Gastroesophageal Junction Neoplasms; Solid tumours; Stomach Neoplasms
Details
BDC-4182BD-4182; BDC-4182Phase 2 ClinicalBolt Biotherapeutics Inc
Adenocarcinoma; Esophageal Neoplasms; Neoplasms; Stomach Neoplasms
Details
LCB-02ALCB-02APhase 2 ClinicalLegochem Biosciences Inc
Hematologic Neoplasms; Solid tumours
Details
PM-1032PM1032; PM-1032Phase 2 ClinicalShanghai Genechem Co Ltd
Neoplasms; Pancreatic Neoplasms
Details
SpevatamigPT-886; PT886Phase 2 ClinicalPhanes Therapeutics Inc
Biliary Tract Neoplasms; Carcinoma, Pancreatic Ductal; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
Details
SKB-315SKB-315; SKB315; MK1200; MK-1200Phase 2 ClinicalSichuan Kelun-Biotech Biopharmaceutical Co Ltd
Esophageal Neoplasms; Solid tumours; Stomach Neoplasms
Details
ATG-022ATG-022; ATN-022Phase 2 ClinicalAntengene Corporation Co Ltd
Gastroesophageal Junction Neoplasms; Solid tumours; Stomach Neoplasms
Details
SOT-102SOT-102; SOT102; SO-N102Phase 2 ClinicalSotio Biotech AG
Pancreatic Neoplasms; Stomach Neoplasms
Details
GivastomigTJ-CD4B; ABL-111; TJ-CLDN4B; TJ-033721; TJ-CD4B/ABL111Phase 2 ClinicalI-Mab Biopharma Co Ltd
Biliary Tract Neoplasms; Carcinoma, Pancreatic Ductal; Esophageal adenocarcinoma; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Neoplasm Metastasis; Neoplasms; Solid tumours; Stomach Neoplasms
Details
Q-1802Q-1802Phase 2 ClinicalQure Biotechnology (Shanghai) Co Ltd
Esophageal Neoplasms; Gastrointestinal Neoplasms; Solid tumours
Details
Recombinant humanized monoclonal antibody MIL93(Mabworks)MIL-93Phase 2 ClinicalBeijing Mabworks Biotech Co Ltd
Gastroesophageal Junction Neoplasms; Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
Details
RC-118RC-118; YH005 ADCPhase 2 Clinical
Gastroesophageal Junction Neoplasms; Solid tumours; Stomach Neoplasms
Details
Recombinant humanized anti-Claudin 18.2 monoclonal antibody (CARsgen)AB-011Phase 1 ClinicalCarsgen Biomedicine (Shanghai) Co Ltd, Kaixing Life Technology (Shanghai) Co Ltd
Esophageal Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
Details
KD-496KD-496(4th); KD-496Phase 1 ClinicalNanjing Kaidi Medical Technology Co Ltd
Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
Details
Claudin18.2 Targeted CAR-T Cells therapy (Frontiergate Biopharm)Phase 1 ClinicalFrontiergate Biopharm (Hainan) Co Ltd
Pancreatic Neoplasms
Details
Claudin18.2 Targeted Activated Dendritic Cells therapy (Frontiergate Biopharm)Phase 1 ClinicalFrontiergate Biopharm (Hainan) Co Ltd
Pancreatic Neoplasms
Details
CBG-131CBG-131; CBG131Phase 1 ClinicalCarbiogene Therapeutics Co Ltd
Pancreatic Neoplasms; Stomach Neoplasms
Details
Claudin18.2 CAR-T cell therapy (Ucello Therapeutics)Phase 1 ClinicalUcello Therapeutics Co Ltd
Solid tumours
Details
GresonitamabAMG-910Phase 1 ClinicalAmgen Inc
Adenocarcinoma; Esophageal Neoplasms; Stomach Neoplasms
Details
Claudin18.2-targeted CAR-DCs therapy (Second Affiliated Hospital School Of Zhejiang University School Of Medicine)Phase 1 ClinicalSecond Affiliated Hospital School Of Zhejiang University School Of Medicine
Colorectal Neoplasms
Details
Claudin18.2-targeted CAR-T Cells therapy (Second Affiliated Hospital School Of Zhejiang University School Of Medicine)Phase 1 ClinicalSecond Affiliated Hospital School Of Zhejiang University School Of Medicine
Colorectal Neoplasms
Details
CT-225XKDCT225; XKDCT-225; CT225Phase 1 ClinicalShenzhen Celconta Life Science Co Ltd
Solid tumours
Details
SIBP-A18SIBPA18; SIBP-A18Phase 1 ClinicalShanghai Institute of Biological Products Co Ltd
Solid tumours
Details
[68Ga]Ga-NODAGA-SNA01468Ga-SNA014; [68Ga]Ga-NODAGA-SNA014; SNA-014Phase 1 ClinicalSmartnuclide Biopharma
Adenocarcinoma; Pancreatic Neoplasms
Details
HD-004HD004; HD-004Phase 1 ClinicalHuadao (Shanghai) Biopharma Co Ltd
Solid tumours
Details
SPX-102SPX-102Phase 1 ClinicalSparx Therapeutics Inc
Neoplasms
Details
Cord Blood-Derived CAR-NK Cells therapy (Rongu Biotechnology)CB CAR-NK182; RG-CLDN18.2Phase 1 ClinicalHangzhou Rongu Biotechnology Co Ltd
Pancreatic Neoplasms; Stomach Neoplasms
Details
LNF-2007LNF-2007; LNF2007Phase 1 ClinicalShandong New Time Pharmaceutical Co Ltd
Solid tumours
Details
BL-M05D1BL-M05D1; BLM05D1Phase 1 ClinicalSichuan Baili Pharmaceutical Co Ltd, SystImmune
Biliary Tract Neoplasms; Carcinoma, Pancreatic Ductal; Esophageal adenocarcinoma; Solid tumours; Stomach Neoplasms
Details
AHT-102AHT102; AHT-102Phase 1 ClinicalGuangxi Lugang Biomedical Technology Co Ltd
Solid tumours
Details
AZD-6422AZD6422; AZD-6422Phase 1 ClinicalAstrazeneca Plc
Gastrointestinal Neoplasms
Details
GC-506GC506; GC-506Phase 1 ClinicalGracell Biotechnologies (Shanghai) Co Ltd
Gastroesophageal Junction Neoplasms; Solid tumours; Stomach Neoplasms
Details
68Ga-PMD22(Peking Union Medical College Hospital)Phase 1 ClinicalPeking Union Medical College Hospital
Gastrointestinal Neoplasms
Details
AK-132AK132; AK-132Phase 1 Clinical
Neoplasms; Solid tumours
Details
AHT-101AHT-101; AHT101Phase 1 ClinicalGuangxi Lugang Biomedical Technology Co Ltd
Solid tumours
Details
TQB-2103TQB2103; TQB-2103Phase 1 ClinicalNanjing Shunxin Pharmaceuticals Co Ltd Of Chiatai Tianqing Pharmaceutical Group
Neoplasms
Details
BIO-008BIO-008Phase 1 ClinicalShijiazhuang Yiling Pharmaceutical Co Ltd
Solid tumours
Details
BA-1301BA-1301; BA1301Phase 1 ClinicalShandong Boan Biotechnology Co Ltd
Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
Details
RB-0011RB0011; RB-0011Phase 1 ClinicalRuiyang (Suzhou) Biological Technology Co Ltd
Solid tumours
Details
LB-1904LB-1904Phase 1 Clinical
Stomach Neoplasms
Details
Ori-C-613Ori-C-613; OriC-613; Ori-C613Phase 1 ClinicalOriCell Therapeutics Co Ltd
Solid tumours
Details
CT-048CT-048; KJ-C1807; KJ-C-1807Phase 1 ClinicalCarsgen Biomedicine (Shanghai) Co Ltd
Gastroesophageal Junction Neoplasms; Pancreatic Neoplasms; Stomach Neoplasms
Details
ASP-2138ASP-2138Phase 1 ClinicalAstellas Pharma Global Development Inc, Xencor Inc
Carcinoma, Pancreatic Ductal; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Pancreatic Neoplasms; Stomach Neoplasms
Details
HEC-016HEC-016Phase 1 ClinicalPeople Hospital Of Luohu,Shenzhen
Esophageal Neoplasms; Pancreatic Neoplasms; Stomach Neoplasms
Details
PM-3023PM-3023Phase 1 Clinical
Solid tumours
Details
RD-07RD-07Phase 1 ClinicalPeking University
Solid tumours
Details
IBI-345IBI-345Phase 1 Clinical
Solid tumours
Details
TORL-2-307-MABTORL-2-307-MABPhase 1 ClinicalTorl Biotherapeutics LLC
Gastroesophageal Junction Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
Details
TORL-2-307-ADCTORL-2-307-ADCPhase 1 ClinicalTorl Biotherapeutics LLC
Gastroesophageal Junction Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
Details
BC-008BC-008Phase 1 ClinicalDragonboat Biopharmaceutical
Neoplasms; Solid tumours
Details
BC-007 (Dragonboat Biopharmaceutical)BC-007Phase 1 ClinicalDragonboat Biopharmaceutical
Neoplasms; Solid tumours
Details
DR-30303DR-30303Phase 1 ClinicalZhejiang Doer Biologics Corp
Solid tumours
Details
SG-1906SG-1906; SG1906Phase 1 ClinicalHangzhou Shangjian Biotechnology Co Ltd
Neoplasms; Solid tumours
Details
BA-1105BA1105; BA-1105Phase 1 ClinicalShandong Boan Biotechnology Co Ltd
Esophageal Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
Details
CLDN 18.2 CAR-T cell therapy (Shanghai Longyao)LY-011Phase 1 ClinicalShanghai Longyao Biological Technology Co Ltd
Pancreatic Neoplasms; Stomach Neoplasms
Details
IBI-389IBI-389Phase 1 Clinical
Esophageal Neoplasms; Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
Details
FL-301NBL-015; FL-301Phase 1 ClinicalNovarock Biotherapeutics Ltd
Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
Details
IBI-360IBI-360Phase 1 Clinical
Neoplasms; Solid tumours
Details
QL-1779QL-1779; QL1779Phase 1 ClinicalQilu Pharmaceutical Co Ltd
Solid tumours
Details
LM-102LM-102Phase 1 ClinicalLaNova Medicines Ltd
Biliary Tract Neoplasms; Esophageal Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
Details
HBM-1029HBM-1029; HBM1029Phase 1 ClinicalHarbour Biomed
Esophageal Neoplasms; Solid tumours; Stomach Neoplasms
Details
LCAR-C18S CAR-T cell therapy (Legend)LB-1908; LCAR-C18S; LCAR-C-18-SPhase 1 Clinical
Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
Details
XKDCT-086XKDCT086; XKDCT-086ClinicalThe Affiliated Hospital Of Qingdao University
Stomach Neoplasms
Details
CLDN18.2 UCAR-T cell therapyCLDN18.2 UCAR-TClinicalT-Maximum Pharmaceutical (Suzhou) Co Ltd
Stomach Neoplasms
Details
124I-18B10124I-18B10; 124-I-18-B-10ClinicalBeijing Cancer Hospital, Transcenta Holding Ltd
Gastrointestinal Neoplasms
Details
CTB-001(Nanjing Bioheng)CTB-001; CTB001ClinicalNanjing Bioheng Biotech Co Ltd
Pancreatic Neoplasms; Stomach Neoplasms
Details
89Zr-NY00589Zr-NY005ClinicalWuxi Nuoyu Pharmaceutical Technology Co Ltd
Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyFirst Brand NameFirst Approved CountryFirst IndicationFirst Approved CompanyFirst Approved DateIndicationClinical Trial
ZolbetuximabGC-182; iMAB-362; IMAB-362ApprovedGanymedVyloy, VYLOY, 威络益JapanStomach NeoplasmsAstellas Pharma Inc2024-03-26
Adenocarcinoma; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Lymphangioma, Cystic; Pain; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
Details
Customer Reviews